High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Explore how Zero-Based Budgeting can outperform Incremental Budgeting by prioritizing needs, justifying every expense, and improving efficiency.
25,905 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
UBS boosts its price target on Xcel Energy to $89 while maintaining a Buy rating, saying the stock could year-end hig...
Commercial Metals posted a blowout quarter in Q2 2026, with revenue hitting $2.132 billion and net income of $93 mill...
President Trump issues an emergency payroll directive for TSA workers as the DHS shutdown drags on, hoping to relieve...
SpaceX may steal headlines, but the real action for investors is in the earnings reports of BlackSky, Redwire, and Ro...
Griffon (GFF) 2026 earnings season offers clues about growth and margins across its portfolio. This guide breaks down...
Markets push higher on resilient earnings and a sturdy job market, with recession risk receding for 2026. Yet traders...
Chevron reports stronger-than-expected Q1 2026 results and advancing Hess synergy-driven production, but investors de...
Colgate-Palmolive posted stronger-than-expected Q1 2026 results, setting the stage for upside despite tariff headwind...
Lime’s IPO plans put micro-mobility in the spotlight. This article explains why a seasoned investor might prefer an e...
Nvidia stock investors just received a wave of bullish commentary from analysts as AI demand powers data centers and ...
Long-term Treasuries moved higher again, signaling tougher borrowing costs ahead. The bond market just handed U.S. ta...